ScandiDos AB (publ) listed on First North, is a world-leading company in quality assurance of modern radiation therapy through advanced measurement and calculation methods. ScandiDos AB announces it has received FDA 510 (k) clearance on its newest product, the Delta4 Phantom+ MR, therefore the product can now be marketed and sold in the U.S. CEO Görgen Nilsson ScandiDos has received the...
ScandiDos AB (publ) listed on First North, is a world-leading company in quality assurance of modern radiation therapy through advanced measurement and calculation methods, has announced a new product within the Delta4 family of products. The Delta4 Phantom+ MR is adapted to be fully compatible with existing MR-linacs and is now released to a large part of the world market. CEO Görgen...
ScandiDos AB, the global leader in Quality Assurance and Dosimetry for modern radiation therapy, has received the first order for its Delta4 Discover system in Mexico from the Instituto Mexicano de Seguro Social (IMSS).
ScandiDos AB and Elekta have signed an Interoperability Agreement for the Delta4 Discover transmission detector
ScandiDos AB, the global leader in Quality Assurance and Dosimetry for modern radiation therapy, has received the first order for its Delta4 Discover system in the United States from The University Medical Center in Lubbock, Texas
The Delta4 Discover transmission detector, a state-of-the-art 4D in-vivo dosimetry system from ScandiDos, is now approved for use by Varian Medical Systems on TrueBeam® and Clinac® Systems